ADVERUM BIOTECHNOLOGIES INC (ADVM)
US00773U2078 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -112.89M | -117.17M | -154.54M | -145.54M | -117.51M | |||
| Depreciation Amortization | 5.05M | 5.64M | 6.53M | 4.65M | 4.16M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | 11.00K | 4.71M | 19.89M | 4.06M | 12.73M | |||
| Other non cash items | 16.10M | 15.91M | 20.03M | 29.00M | 21.33M | |||
| OPERATING CASH FLOW | -91.74M | -90.90M | -108.09M | -107.83M | -79.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -808.00K | -808.00K | -11.82M | -15.12M | -11.84M | |||
| Other Investing Activity | 54.13M | 97.68M | 153.54M | 93.83M | -268.32M | |||
| INVESTING CASH FLOW | 53.32M | 96.88M | 141.72M | 78.71M | -280.17M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -240.00K | -60.00K | |||
| Stock Issued/Repurchased | 120.37M | 489.00K | 610.00K | 2.64M | 358.09M | |||
| Other Financing Activity | N/A | -420.00K | N/A | 0.00 | -2.04M | |||
| FINANCING CASH FLOW | 119.95M | 69.00K | 610.00K | 2.40M | 355.99M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 81.53M | 6.04M | 34.24M | -26.72M | -3.47M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -91.74M | -90.90M | -108.09M | -107.83M | -79.29M | |||
| Capital Expenditure | -808.00K | -808.00K | -11.82M | -15.12M | -11.84M | |||
| FREE CASH FLOW | -92.55M | -91.71M | -119.91M | -122.95M | -91.13M | |||
All data in USD